Streetbeat News

Regulatory

MEDIF

MediPharm Labs Corp. has received GMP certification from ANVISA for its facility in Barrie, Ontario, enabling it to produce medical cannabis products for the Brazilian market. This adds to its existing certifications from the FDA, EU, Australia's TGA, and Health Canada. The Brazilian medical cannabis market is expected to reach $281.2 million by 2025. MediPharm has two products with full ANVISA authorization and is reviewing additional products. It also has a supply agreement with a Brazilian pharmaceutical company and a partnership with a Rio distributor. MediPharm's shares rose 2.6923% to $0.0534 after the announcement.

Portfolio Pulse from Jelena Martinovic

February 07, 2024 | 4:05 pm

SPY

Fed's Kugler expects consumer spending to slow down this year, aiding in disflation. Despite some easing, financial conditions remain tight, aligning with ongoing progress on inflation.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:04 pm

SPY

Fed's Kugler expressed satisfaction that the cooling of labor demand has not resulted in increased layoffs, but noted that the evolution of spending momentum throughout the year remains uncertain and could impact the disinflationary process.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:04 pm

SPY

Kugler comments on the current state of core-services excluding housing, noting they remain elevated but are expected to improve. The continued moderation of wage growth, normalization of price-setting, and anchored inflation expectations are likely to contribute to ongoing disinflation.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:03 pm

SPY

Fed's Kugler expressed that if progress on disinflation stalls, it might be appropriate to maintain the current policy rate for an extended period. He also mentioned 'reasons for optimism' regarding services inflation, which has shown less progress.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:03 pm

SPY

Fed's Kugler comments on the current economic situation, stating that risks to the dual mandate are balanced and the policy stance is restrictive. He suggests that future cooling in inflation and labor markets could justify a rate cut.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:02 pm

SPY

Fed's Kugler expressed satisfaction with the progress on inflation reduction, remaining optimistic about its continuation. However, he emphasized that the Fed's job on inflation is not yet complete and will stay focused on the inflation goal until it durably returns to the 2% target.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:01 pm

AAPL

ISS, a proxy advisory group, has recommended that Apple shareholders vote in favor of two shareholder proposals. The first proposal calls for a report on the median gender and racial pay gap within the company. The second proposal seeks a report on the use of artificial intelligence by Apple. These recommendations were reported by Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:25 pm

BA

RYAAY

Ryanair CEO O'Leary expressed concerns that increased FAA supervision in Seattle could slow down operations, potentially affecting the airline's deliveries through the end of June, as reported by Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:20 pm

GILD

Gilead Sciences is currently reviewing the safety of Magrolimab in all ongoing solid tumor trials and has committed to providing an update on this assessment as soon as possible, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 3:16 pm